News

  • 6 Jul 2021 8:58 PM | Onondaga Society (Administrator)

    In light of the expiration of the State of Emergency necessitated by the COVID-19 pandemic, the Workers’ Compensation Board (Board) will be returning to more regular operations on June 29, 2021.  All of the guidance and modifications provided on the Board’s webpage relating to the State of Emergency are lifted, with the following exceptions:

    • The suspension of the Labor Market Attachment requirement will expire on August 16, 2021. Visit the Board's website to view the guidance. 
    • Relief from the original signature requirements on 27 Board prescribed forms will continue until August 16, 2021.
    • Board offices remain closed for the time being and contact with Board employees will be by phone and email only.
    • Remote-only attendance at hearings will continue, with parties and witnesses appearing by video through the Virtual Hearing Center or, as an option for claimants only, by telephone.
    • Consideration of requests for the extension of the 30-day filing requirement will continue for appeals and rebuttals post-marked through July 6, 2021.
    • Personal service on the Board still will not be permitted. Service will continue to be by mail only.
    • Telehealth will remain in effect by Emergency Regulation. A permanent telehealth regulation is expected to be released for public comment shortly.

    More information

    This information is also available on the Board’s website.

    Questions? Email OfficeofGeneralCounsel@wcb.ny.gov.


  • 30 Mar 2021 2:07 PM | Onondaga Society (Administrator)

    OCMS is happy to share the news that Governor Cuomo announced today New York has opened COVID-19 vaccinations to people 30 and up on Tuesday, 3/30, and will make all residents 16 and over eligible to receive a coronavirus vaccine on April 6.

    The Onondaga County Medical Society strongly supports this decision—it is time to expand vaccine eligibility to all adults willing to be immunized.  

    Enabling physicians to vaccinate any adult will increase vaccination rates and help overcome much of the vaccine hesitancy in patients who would first like to get more information about their particular situation and have the opportunity to discuss their concerns with their primary care physician.

    Allowing all people over the age of 16 to be vaccinated will have an enormous positive impact on efforts to stop the transmission of COVID-19 in New York, and provide us with the best chance of returning to some semblance of normalcy by July 4th.

    Trust physicians to help all their patients get the COVID-19 vaccination—and help increase access for everyone.



  • 19 Mar 2021 3:34 PM | Onondaga Society (Administrator)

    A new Harvard study suggests that sitting kids closer in the classroom doesn’t spread COVID-19 any faster.

    The Centers for Disease Control and Prevention is considering reducing the distance in classrooms from 6 feet to 3 feet following the findings from the study. Students and staff members in the study wore masks.

    “We are taking all of those data carefully and revisiting our guidances in that context,” says CDC Director Dr. Rochelle Walensky. Dr. Frederick Davis, of Northwell Health, says schools should wait until more adults are vaccinated before making the change. Davis says kids usually don’t get as severe a disease and sometimes are asymptomatic, but they can still bring it home and spread it to family members.

    The CDC has not given a date for a possible decision, but the World Health Organization has already recommended three feet as a safe distance.


  • 19 Mar 2021 3:30 PM | Onondaga Society (Administrator)

    A number of recent studies have focused on COVID-19 vaccine efficacy, hospitalization trends and variants.

    Here are 15 findings from studies published since March 3:

    1. Pfizer said March 11 that its COVID-19 vaccine prevented 94 percent of asymptomatic cases.
    2. Novavax’s COVID-19 vaccine candidate was 96.4 percent effective in preventing COVID- 19 in its phase 3 K. trial.
    3. Eli Lilly said March 10 its COVID-19 antibody cocktail reduced the risk of hospitalization and death by 87 percent during a recent phase 3.
    4. GlaxoSmithKline and Vir Biotechnology said March 10 that their COVID-19 antibody drug was 85 percent effective at reducing virus-related hospitalizations and death in a phase 3 clinical trial.
    5. Despite few hospitalized COVID-19 patients having a bacterial infection, 52 percent of hospitalizations led to at least one antibiotic prescription, according to the Pew Charitable Trusts’ Antibiotic Resistance Project published March 10.
    6. People who have more than five symptoms of COVID-19 during the first week of illness may be more likely to develop prolonged health issues, known as “long COVID-19,” according to a study published March 10 in Nature
    7. Patients ages 30 and older infected with the K. coronavirus variant had a 64 percent higher death risk than those infected with previously circulating strains, according to a U.K. study published March 10 in The BMJ.
    8. People who received both doses of Pfizer-BioNTech’s messenger RNA vaccine and had no symptoms had an 80 percent lower risk of testing positive for COVID-19 compared to those who were unvaccinated, according to research published March 10 in Clinical Infectious The findings suggest mRNA vaccines are effective at reducing the risk of asymptomatic infection.
    9. Among 71,491 S. adults who were hospitalized with COVID-19, 27.8 percent were overweight and 50.2 percent were obese, according to the CDC’s latest Morbidity and Mortality Weekly Report published March 8.
    10. Just 0.025 percent of staff from Massachusetts General Hospital and Brigham and Women’s Hospital experienced anaphylaxis after receiving Pfizer or Moderna COVID-19 vaccines, according to a study published March 8 in JAMA.
    11. The COVID-19 vaccine developed by Pfizer and BioNTech was shown to be 95 percent effective in neutralizing a more contagious variant of the novel coronavirus that was discovered in Brazil, according to a study published March 8 in the New England Journal of Medicine.
    12. Both Pfizer’s and Moderna’s COVID-19 vaccines were at least 10 times less effective against a virus variant first found in South Africa in a small study conducted by researchers from Columbia University, Business Insider reported March 8.
    13. In-hospital mortality for COVID-19 patients fell 15 percentage points from March to August 2020, according to a study published March 5 in JAMA Network Open.
    14. Among 152 children hospitalized with COVID-19, 18, or 12 percent, developed acute kidney injury, according to a study published March 3 in Kidney International.
    15. The SARS-CoV-2 virus may more easily bind to the airway cells of people with Type A blood, according to a study published March 3 in Blood Advances.


  • 19 Mar 2021 3:22 PM | Onondaga Society (Administrator)

    Effective March 17, enrolled providers other than pharmacies, may vaccinate any eligible individual. Pharmacies must continue to vaccinate individuals age 60 and older, and prioritize P-12 school faculty and staff, and childcare worker per federal guidance, however are now authorized to vaccinate individuals with comorbidities or underlying conditions. All providers must make efforts to vaccinate the most vulnerable New Yorkers, including those with comorbidities or underlying conditions, and individuals 60+.

    Effective March 17, public-facing government and public employees, not-for-profit workers who provide public-facing services to New Yorkers in need, and essential in-person public-facing building service workers and providers of essential building services are eligible to be vaccinated. Read the full guidance report here.


  • 19 Mar 2021 3:20 PM | Onondaga Society (Administrator)

    MSSNY Update 3-5-2021: Physician Advocacy Day Success; Continued Need for Advocacy and Vaccine Accessibility Click here!

Onondaga County Medical Society, 125 East Jefferson St; 1st Floor Lobby; Syracuse, NY 13202

Powered by Wild Apricot Membership Software